Literature DB >> 1658303

Characterization of sulfonylurea receptors and the action of potassium channel openers on cholinergic neurotransmission in guinea pig isolated small intestine.

S Zini1, Y Ben-Ari, M L Ashford.   

Abstract

Specific binding sites for [3H]glibenclamide, a potent ATP-sensitive K+ channel blocker, have been characterized in the isolated guinea pig longitudinal muscle-myenteric plexus preparation. The Scatchard plot of the saturation isotherm was curvilinear and revealed two binding sites, one of high affinity (Kd = 0.42 nM; maximum binding site = 156 fmol/mg of protein), the other of low affinity (Kd = 83 nM; maximum binding site = 3100 fmol/mg of protein). Displacement experiments in the presence of various sulfonylureas showed the same order of potency for the two binding sites (glibenclamide greater than gliquidone greater than glipizide glibornuride greater than chlorpropamide greater than tolbutamide). The K+ channel opener RP 49356 (but not diazoxide or cromakalim) displaced the [3H] glibenclamide with an IC50 of 4.8 microM. The effects of the K+ channel openers diazoxide, RP 49356, cromakalim and its two optical isomers BRL 38226 and BRL 38227 were also studied on the electrically induced contractions of isolated guinea pig small intestine. These compounds produce an inhibition of neurally evoked twitch height with pD2 values of 4.5 to 6.2 (BRL 38227 greater than cromakalim greater than RP 49356 greater than diazoxide, whereas BRL 38226 was practically ineffective). The effects of cromakalim and RP 49356 were antagonized competitively by glibenclamide (pA2 = 7.2) and other sulfonylureas, suggesting they act on ATP-sensitive K+ channels. Affinities of the sulfonylureas obtained from concentration-response curves to cromakalim on electrically induced contractions are better correlated with the IC50 value corresponding to the low affinity binding site than to the high affinity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658303

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Identification and characterization of glucoresponsive neurons in the enteric nervous system.

Authors:  M Liu; S Seino; A L Kirchgessner
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

Review 3.  Multiplicity of effectors of the cardioprotective agent, diazoxide.

Authors:  William A Coetzee
Journal:  Pharmacol Ther       Date:  2013-06-19       Impact factor: 12.310

Review 4.  Sulfonylurea receptor 1 subunits of ATP-sensitive potassium channels and myocardial ischemia/reperfusion injury.

Authors:  David J Lefer; Colin G Nichols; William A Coetzee
Journal:  Trends Cardiovasc Med       Date:  2009-02       Impact factor: 6.677

5.  Sulphonylureas reduce the slowly inactivating D-type outward current in rat hippocampal neurons.

Authors:  V Crépel; K Krnjević; Y Ben-Ari
Journal:  J Physiol       Date:  1993-07       Impact factor: 5.182

6.  Effect of cromakalim and glibenclamide on spontaneous and evoked motility of the guinea-pig isolated renal pelvis and ureter.

Authors:  C A Maggi; S Giuliani; P Santicioli
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

7.  Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels.

Authors:  M J During; P Leone; K E Davis; D Kerr; R S Sherwin
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

8.  Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics.

Authors:  B A Conley; S O'Hara; S Wu; T J Melink; H Parnes; E Pardoe; M J Egorin; D A Van Echo
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Short-Term High-Fat Diet (HFD) Induced Anxiety-Like Behaviors and Cognitive Impairment Are Improved with Treatment by Glyburide.

Authors:  Stephen J Gainey; Kristin A Kwakwa; Julie K Bray; Melissa M Pillote; Vincent L Tir; Albert E Towers; Gregory G Freund
Journal:  Front Behav Neurosci       Date:  2016-08-11       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.